We could not find any results for: Make sure your spelling is correct or try broadening your search.
It looks like you aren't logged in.Click the button below to log in and view your recent history.
Already a member? Sign in
Pepperstone
Trade Now
Connect with traders and investors in our Follow Feed community.
Explore comprehensive options data and use advanced filters with Options Flow.
Organize and monitor your stock and asset watchlist with Monitor.
TR-1: Standard form for notification of major holdings
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i
1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:
ABINGDON HEALTH PLC
1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)
Non-UK issuer
2. Reason for the notification (please mark the appropriate box or boxes with an "X")
An acquisition or disposal of voting rights
X
An acquisition or disposal of financial instruments
An event changing the breakdown of voting rights
Other (please specify)iii:
3. Details of person subject to the notification obligationiv
Name
CANACCORD GENUITY GROUP INC
City and country of registered office (if applicable)
VANCOUVER, CANADA
4. Full name of shareholder(s) (if different from 3.)v
DISCRETIONARY CLIENTS
As above
5. Date on which the threshold was crossed or reachedvi:
14 AUGUST 2024
6. Date on which issuer notified (DD/MM/YYYY):
16 AUGUST 2024
7. Total positions of person(s) subject to the notification obligation
% of voting rights attached to shares (total of 8. A)
% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)
Total of both in % (8.A + 8.B)
Total number of voting rights held in issuer (8.A + 8.B) vii
Resulting situation on the date on which threshold was crossed or reached
9.8679
18,702,013
Position of previous notification (if
applicable)
N/A
8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii
A: Voting rights attached to shares
Class/type of shares
ISIN code (if possible)
Number of voting rightsix
% of voting rights
Direct
(DTR5.1)
Indirect
(DTR5.2.1)
GB00BLF79J41
SUBTOTAL 8. A
B 1: Financial Instruments according to DTR5.3.1R (1) (a)
Type of financial instrument
Expiration datex
Exercise/ Conversion Periodxi
Number of voting rights that may be acquired if the instrument is
exercised/converted.
SUBTOTAL 8. B 1
B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)
Exercise/ Conversion Period xi
Physical or cash
settlementxii
Number of voting rights
SUBTOTAL 8.B.2
9. Information in relation to the person subject to the notification obligation (please mark the
applicable box with an "X")
Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii
Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)
Namexv
% of voting rights if it equals or is higher than the notifiable threshold
% of voting rights through financial instruments if it equals or is higher than the notifiable threshold
Total of both if it equals or is higher than the notifiable threshold
Canaccord Genuity Group Inc.
Canaccord Genuity Wealth Group Holdings Limited
Canaccord Genuity Wealth Group Holdings (Jersey) Limited
Canaccord Genuity Wealth Group Limited
Canaccord Genuity Asset Management Limited
10. In case of proxy voting, please identify:
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
11. Additional informationxvi
The change in the percentage of shares held is due entirely to participation in the placing by Abingdon Health plc, the shares from which were admitted to trading on AIM on 14/08/2024.
Place of completion
BLACKPOOL, ENGLAND
Date of completion
19 AUGUST 2024
More Abingdon Health PLC News Articles
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions